Literature DB >> 8901633

Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

S W Curtis1, T Washburn, C Sewall, R DiAugustine, J Lindzey, J F Couse, K S Korach.   

Abstract

Past studies have shown that epidermal growth factor (EGF) is able to mimic the uterotropic effects of estrogen in the rodent. These studies have suggested a "cross-talk" model in which EGF receptor (EGF-R) signaling results in activation of nuclear estrogen receptor (ER) and its target genes in an estrogen-independent manner. Furthermore, in vitro studies have indicated the requirement for ER in this mechanism. To verify the requirement for ER in an in vivo system, EGF effects were studied in the uteri of ER knockout (ERKO) mice, which lack functional ER. The EGF-R levels, autophosphorylation, and c-fos induction were observed at equivalent levels in both genotypes indicating that removal of ER did not disrupt the EGF responses. Induction of DNA synthesis and the progesterone receptor gene in the uterus were measured after EGF treatment of both ERKO and wild-type animals. Wild-type mice showed increases of 4.3-fold in DNA synthesis, as well as an increase in PR mRNA after EGF treatment. However, these responses were absent in ERKO mice, confirming that the estrogen-like effects of EGF in the mouse uterus do indeed require the ER. These data conclusively demonstrate the coupling of EGF and ER signaling pathways in the rodent reproductive tract.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901633      PMCID: PMC38043          DOI: 10.1073/pnas.93.22.12626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Identification of constitutive and steroid-dependent transactivation domains in the mouse oestrogen receptor.

Authors:  J A Lees; S E Fawell; M G Parker
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

2.  Dopaminergic and ligand-independent activation of steroid hormone receptors.

Authors:  R F Power; S K Mani; J Codina; O M Conneely; B W O'Malley
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 3.  Regulation of the uterine epidermal growth factor receptor by estrogen.

Authors:  G M Stancel; C Chiapetta; R M Gardner; J L Kirkland; T H Lin; R B Lingham; D S Loose-Mitchell; V R Mukku; C A Orengo
Journal:  Prog Clin Biol Res       Date:  1990

4.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.

Authors:  D M Ignar-Trowbridge; K G Nelson; M C Bidwell; S W Curtis; T F Washburn; J A McLachlan; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Regulation of progesterone receptor-mediated transcription by phosphorylation.

Authors:  L A Denner; N L Weigel; B L Maxwell; W T Schrader; B W O'Malley
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

6.  Dopamine activation of an orphan of the steroid receptor superfamily.

Authors:  R F Power; J P Lydon; O M Conneely; B W O'Malley
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

7.  Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast.

Authors:  D Metzger; R Losson; J M Bornert; Y Lemoine; P Chambon
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

8.  Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.

Authors:  S M Aronica; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1991-04       Impact factor: 4.736

9.  Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation.

Authors:  K G Nelson; T Takahashi; N L Bossert; D K Walmer; J A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue.

Authors:  M K Gibson; L A Nemmers; W C Beckman; V L Davis; S W Curtis; K S Korach
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

View more
  61 in total

1.  The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

Authors:  B Moosmann; C Behl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse.

Authors:  J L Fendrick; A M Raafat; S Z Haslam
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 3.  Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation".

Authors:  Jr-Gang Cheng; Clara I Rodriguez; Colin L Stewart
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

Review 4.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Authors:  Paul H Driggers; James H Segars
Journal:  Trends Endocrinol Metab       Date:  2002-12       Impact factor: 12.015

Review 5.  Mammary gland development and tumorigenesis in estrogen receptor knockout mice.

Authors:  W P Bocchinfuso; K S Korach
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

Review 6.  Estrogen receptors: structure, mechanisms and function.

Authors:  Sylvia Curtis Hewitt; Kenneth S Korach
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

7.  Uterine epithelial estrogen receptor α is dispensable for proliferation but essential for complete biological and biochemical responses.

Authors:  Wipawee Winuthayanon; Sylvia C Hewitt; Grant D Orvis; Richard R Behringer; Kenneth S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 8.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

9.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

Review 10.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.